EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+15.48%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$1.02B
AUM Growth
+$1.02B
(+13%)
Cap. Flow
+$16.2M
Cap. Flow
% of AUM
1.59%
Top 10 Holdings %
Top 10 Hldgs %
63.41%
Holding
72
New
4
Increased
21
Reduced
27
Closed
10
Top Buys
| 1 |
Inspire Medical Systems
INSP
|
$32.2M |
| 2 |
argenx
ARGX
|
$30.9M |
| 3 |
IMGN
Immunogen Inc
IMGN
|
$22.2M |
| 4 |
Syndax Pharmaceuticals
SNDX
|
$17M |
| 5 |
Revvity
RVTY
|
$16.4M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$23.8M |
| 2 |
Natera
NTRA
|
$15.1M |
| 3 |
Danaher
DHR
|
$14.5M |
| 4 |
Illumina
ILMN
|
$11.2M |
| 5 |
Amneal Pharmaceuticals
AMRX
|
$11.2M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Natera
NTRA
$23.1B
| $141M | 12.39% | 2,251,588 -241,048 | -10% | -$15.1M |
|
2
GSK
GSK
$79.9B
| $110M | 9.68% | 2,972,954 -286,388 | -9% | -$10.6M |
|
|
3
Syndax Pharmaceuticals
SNDX
$1.41B
| $73.1M | 6.42% | 3,383,244 +786,999 | +30% | +$17M |
|
|
4
Inspire Medical Systems
INSP
$2.77B
| $71.4M | 6.28% | 351,116 +158,098 | +82% | +$32.2M |
|
5
Teva Pharmaceuticals
TEVA
$21.1B
| $64.3M | 5.64% | 6,154,354 -797,731 | -11% | -$8.33M |
|
6
United Therapeutics
UTHR
$13.8B
| $54.1M | 4.76% | 246,234 -21,669 | -8% | -$4.76M |
|
7
Bio-Techne
TECH
$8.5B
| $35.9M | 3.15% | 465,307 +79,418 | +21% | +$6.13M |
|
8
HealthEquity
HQY
$7.72B
| $32.8M | 2.88% | 494,919 +156,403 | +46% | +$10.4M |
|
|
9
argenx
ARGX
$43.6B
| $32.7M | 2.87% | 85,832 +81,267 | +1,780% | +$30.9M |
|
10
HCA Healthcare
HCA
$94.5B
| $31.1M | 2.73% | 114,805 +4,732 | +4% | +$1.28M |
|
11
Celldex Therapeutics
CLDX
$1.47B
| $29.9M | 2.63% | 754,107 +165,964 | +28% | +$6.58M |
|
12
Vera Therapeutics
VERA
$1.38B
| $29.5M | 2.59% | 1,914,830 +436,341 | +30% | +$6.71M |
|
13
Community Health Systems
CYH
$387M
| $22.6M | 1.99% | 7,231,126 +85,038 | +1% | +$266K |
|
|
IMGN
14
DELISTED
Immunogen Inc
IMGN
| $22.2M | 1.95% | +748,950 | New | +$22.2M |
|
|
15
Revvity
RVTY
$10.5B
| $20M | 1.76% | 183,059 +150,361 | +460% | +$16.4M |
|
16
Ionis Pharmaceuticals
IONS
$6.79B
| $16.4M | 1.44% | 324,654 +72,208 | +29% | +$3.65M |
|
17
Vaxcyte
PCVX
$4B
| $14.7M | 1.29% | 233,839 +43,409 | +23% | +$2.73M |
|
|
SWAV
18
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $14.4M | 1.27% | 75,822 -8,640 | -10% | -$1.65M |
|
19
Tenet Healthcare
THC
$16.3B
| $14.2M | 1.24% | +187,265 | New | +$14.2M |
|
20
Protagonist Therapeutics
PTGX
$3.67B
| $12.3M | 1.08% | 538,074 +251,326 | +88% | +$5.76M |
|
|
21
Illumina
ILMN
$15.8B
| $12.1M | 1.06% | 86,614 -80,168 | -48% | -$11.2M |
|
|
TARO
22
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $10.7M | 0.94% | 255,988 +665 | +0.3% | +$27.8K |
|
23
Krystal Biotech
KRYS
$4.27B
| $10M | 0.88% | 80,798 -27,973 | -26% | -$3.47M |
|
24
ZimVie
ZIMV
$532M
| $9.7M | 0.85% | +546,444 | New | +$9.7M |
|
|
25
Danaher
DHR
$147B
| $9.49M | 0.83% | 41,041 -62,743 | -60% | -$14.5M |
|